Vera Therapeutics VERA Pre-Tax Income
Pre-Tax Income at other companies
Other financials
Where this comes from
Reported directly by Vera Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.
The official record: Vera Therapeutics’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vera Therapeutics's pre-tax income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vera Therapeutics's pre-tax income?
- Vera Therapeutics (VERA) reported pre-tax income of -$74.9M in Q4 2025.
- How has Vera Therapeutics's pre-tax income changed year-over-year?
- Vera Therapeutics's pre-tax income decreased by 96.9% year-over-year, from -$38.04M to -$74.9M.
- What is the long-term trend for Vera Therapeutics's pre-tax income?
- Over 4 years (2021 to 2025), Vera Therapeutics's pre-tax income has grown at a 74.1% compound annual growth rate (CAGR), from -$32.61M to -$299.61M.
- What does pre-tax income mean?
- Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.